← Leaderboards
Csaba Pal Kovesdy
Memphis Va Medical Center
$1,692,340
Attributed
$4,622,345
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $899.3K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,622,345 · 3
VA$0 · 2
By mechanism
U01$2,825,790 · 1
R01$1,796,555 · 2
I01$0 · 2
Top collaborators
- Kamyar Kalantar-Zadeh11 shared
- Steven J Jacobsen5 shared
- Susmita Datta3 shared
- Keiichi Sumida3 shared
- Mark Lynn Unruh3 shared
Others in their field
Top investigators on “Veterans”
- David R. Weir · University Of Michigan At Ann Arbor$296,295,927
- Charles A Coltman · Southwest Oncology Group$122,561,996
- Jennifer A Pietenpol · Vanderbilt University$60,636,894
- Fred M Gordin · Social And Scientific Systems, Inc.$59,139,975
- Adrian Hernandez · Duke University$50,769,596
- Michael W. Konstan · Case Western Reserve University$48,783,827
Research focus
VeteransEventChronic Kidney FailureKidney DiseasesDisease ProgressionEnd Stage Renal FailureCardiovascular SystemCaringDatabasesMineralsKidneyHypercholesterolemiaAnemiaCohortObesityClinical TrialsPharmaceutical PreparationsCostComorbidityMortalityRenal FunctionBiochemicalMalnutritionDialysis Procedure
Grant awards (18)
Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial$296,464
R01 · FY2025 · DK
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets): A Pragmatic, Multi-Center, Randomized Controlled Trial$0
I01 · FY2025 · VA
Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial$281,924
R01 · FY2024 · DK
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets): A Pragmatic, Multi-Center, Randomized Controlled Trial$0
I01 · FY2024 · VA
Therapeutic Interventions to Access Outcomes and Disparities in Chronic Kidney Disease Among Veterans$0
I01 · FY2024 · VA · contact PI
Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial$308,818
R01 · FY2023 · DK
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets): A Pragmatic, Multi-Center, Randomized Controlled Trial$0
I01 · FY2023 · VA
Therapeutic Interventions to Access Outcomes and Disparities in Chronic Kidney Disease Among Veterans$0
I01 · FY2022 · VA · contact PI
Therapeutic Interventions to Access Outcomes and Disparities in Chronic Kidney Disease Among Veterans$0
I01 · FY2021 · VA · contact PI
Therapeutic Interventions to Access Outcomes and Disparities in Chronic Kidney Disease Among Veterans$0
I01 · FY2020 · VA · contact PI
Transition of Care in CKD (TC-CKD)$541,331
U01 · FY2018 · DK
Transition of Care in CKD (TC-CKD)$554,000
U01 · FY2017 · DK
Transition of Care in CKD (TC-CKD)$561,587
U01 · FY2016 · DK
Transition of Care in CKD (TC-CKD)$569,175
U01 · FY2015 · DK
Racial and Cardiovascular Risk Factor Anomalies in CKD$300,017
R01 · FY2015 · DK · contact PI
Transition of Care in CKD (TC-CKD)$599,697
U01 · FY2014 · DK
Racial and Cardiovascular Risk Factor Anomalies in CKD$299,596
R01 · FY2014 · DK · contact PI
Racial and Cardiovascular Risk Factor Anomalies in CKD$309,736
R01 · FY2013 · DK · contact PI